Drug Discovery Agent – Prognica Labs

Asset Discovery Agent

Autonomous AI for Intelligent Drug Asset Mining and Evaluation

The Asset Discovery Agent is an AI-powered system designed to autonomously identify and evaluate overlooked, underutilized, or abandoned drug assets across scientific and commercial domains. By integrating deep language models, biomedical ontologies, and knowledge graphs, it discovers hidden therapeutic opportunities with real translational potential, bridging the gap between data abundance and drug innovation.

Pharma & Biotech
Identify shelved or orphaned compounds with renewed potential

VCs & Accelerators
Rapid due diligence on early-stage or discontinued assets

Research Institutes
Discover cross-domain applications of existing molecules

IP Firms
Analyze global patent landscapes for competitive intelligence

Continuously scans and aggregates data from public and private sources – including biomedical literature, patent databases, preclinical and clinical repositories, molecular databases, and regulatory filings.
Uses advanced semantic parsing and entity linking to interpret unstructured text & extract compound–target–disease relationships.

Employs multimodal AI models trained on chemical, biological, and clinical features to detect patterns indicative of therapeutic potential.
Ranks candidates based on novelty, safety, efficacy signals, and clinical feasibility scores.

Cross-validates assets against disease pathways, biomarker data, and molecular docking predictions to evaluate clinical relevance and repurposability. Integrates proprietary de-risking matrix that simulates early clinical outcomes and identifies assets with a favorable risk–reward profile.

Expert pharmacologists and clinicians review AI-generated insights to ensure scientific rigor and contextual accuracy. The final output includes reports with detailed rationale, supporting evidence, and recommendations for licensing.

End-to-End Automation
From data ingestion to candidate selection.

Explainable AI
Transparent evidence trail for every recommendation.

Cross-Domain
Connects chemical, clinical, and commercial signals.

Speed & Efficiency
Reduces asset discovery timelines from months to hours.

Want to see a demo or
got a question, idea, or partnership in mind?